Investigating how ectopic fat affects heart attack risk in people living with HIV
Official title: The Association of Ectopic Fat and Cardiovascular Disease in People Living With HIV and General Populations: A Cross Sectional Analysis
Run by University of Liverpool · NCT06784154 · Data updated 2026-11-12
This study looks at how extra fat around organs affects the risk of heart attacks in people living with HIV to help improve their heart health.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Liverpool Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Liverpool) |
| Status | Recruiting |
| Started | August 1, 2024 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | February 19, 2026 |
| Trial ID | NCT06784154 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are HIV-positive individuals over 40 years old who have been on stable antiretroviral therapy for at least six months.
✕Probably not a fit
Patients with severe renal or hepatic impairment, active hepatitis, or those currently using GLP-1 agonists may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the differences in energy utilization and storage between people living with HIV (PLWHIV) and the general population. Using magnetic resonance imaging (MRI), the study will measure visceral fat around organs such as the heart and liver, which is linked to metabolic syndrome and cardiovascular disease. The research focuses on understanding how factors related to HIV and antiretroviral therapy contribute to increased cardiovascular risk. By identifying these mechanisms, the study seeks to improve risk prediction and management for PLWHIV.
Why it matters
Potential benefit: If successful, this study could lead to better risk assessment and management strategies for cardiovascular disease in people living with HIV.
How similar studies have gone: While there is ongoing research into cardiovascular risks in PLWHIV, this specific focus on ectopic fat and its implications is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • \>40 years * HIV-positive * Stable ART for \>6 months with two VL \<40 copies/ml based on local testing protocols * CD4 count \>200cells/mm3 for \>2 years from recruitment Inclusion Criteria (all) * Understand the study procedures, able to comply with study procedures and voluntarily agree to participate by giving informed written consent Exclusion Criteria: * Subjects unable to comply with the study protocol * History of severe renal impairment (eGFR \<30ml/min) * History of severe hepatic impairment (Child Pugh Score \>9) * Active hepatitis B or hepatitis C * Any active illness, which in the opinion of the investigator precludes participation in the study. * History of cancer * Active illicit intravenous drug use * Investigators may decide the subject cannot proceed if there are any relevant other abnormal results in screening assessments * History or current GLP-1 agonist use * For female subjects: pregnancy or breast feeding at screening. * Subjects currently taking: Atypical antipsychotics, omega 3 supplements, Telmisartan/Irbesartan, Thiazolidinediones or regular NSAID use. * Familial hypercholesterolaemia
Where it's running
-
Royal Liverpool University Hospital
Liverpool, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV
This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.
-
HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters
This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.
-
Stigma-reducing program to help women who use drugs stay in HIV care
This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.
-
Platelets and HIV Reservoirs: A look at how platelets might harbor HIV in people living with HIV
This observational study tests whether HIV can be found inside platelets in adults with suppressed HIV on therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.